New York – Leerink Swann, a noted US-based, healthcare-focused investment bank, research provider, and expert network, has recently formed an alliance with Swiss company InterPharmaLink. The partnership will enable Leerink’s strategic advisory group to access InterPharmaLink’s network and business platform in Europe and Japan. Reciprocally, InterPharmaLink will gain insight into the US healthcare market through Leerink Swann.
Leerink’s expert network and research business is one of the leading research providers focused on US healthcare. It seems at this point that the partnership with InterPharmaLink is going to primarily benefit Leerink’s corporate advisory business, but it may also lead to some benefits down the road for Leerink’s research and expert network business. Partnering with a firm like InterPharmaLink may give Leerink a significant advantage in expanding its coverage of healthcare in Europe and Asia.
The full press release is below:
BASEL, Switzerland and BOSTON–(Business Wire)–
Healthcare-focused US investment bank Leerink Swann has formed a global
collaboration with Swiss company InterPharmaLink.Leerink Swann is a leading healthcare investment bank and specializes in equity
research, corporate finance, strategic advisory and asset management services.
InterPharmaLink is a leading provider of professional business development
services to healthcare companies.The collaboration enables Leerink Swann`s Strategic Advisory Group to access
InterPharmaLink`s extensive network and business platform in Europe and Japan.
The Strategic Advisory Group at Leerink Swann provides strategic advice to
leading healthcare companies in areas including corporate strategy, therapeutic
area strategy and specific product/device strategy.InterPharmaLink will now have the ability to gain in-depth insight into the US
healthcare market through Leerink Swann`s unique and powerful business platform.“I am delighted about this partnership,” said Michael Jenkins, Senior Managing
Director and Head of Leerink Swann Strategic Advisors. “InterPharmaLink`s
Principals have an extensive network and perennial professional experience in
the pharmaceutical world, particularly in Europe and Japan, which are highly
attractive markets for us.”Dr. Raimund Eckel, CEO of InterPharmaLink added, “Collaborating with a highly
regarded and well known healthcare firm like Leerink Swann will enhance
InterPharmaLink`s access to US healthcare companies and knowledge about the
American pharma and biotech markets. This is a very important step for us and
our global efforts in business development.”About InterPharmaLink
InterPharmaLink is a leading provider of professional business development
services to Pharma and Biotech companies. The company is transaction-oriented
and helps its clients to create incremental value through Partnering and Mergers
& Acquisitions on a global scale. InterPharmaLink`s Principals and Senior
Advisors are experienced executives from within the pharmaceutical and
management consulting industry. For more information, visit
www.interpharmalink.com.About Leerink Swann
Leerink Swann is a healthcare-focused investment banking firm that provides
equity research, corporate finance, strategic advisory and asset management
services for institutional, life sciences and high-net-worth clients. Every year
since 2001, Institutional Investor has named Leerink Swann “Best of the
Boutiques” in several healthcare categories. Through its MEDACorp division,
Leerink Swann provides biomedical-consulting services to the institutional
investment community. With an internal team of experts and a dedicated external
network of academic and community healthcare professionals, MEDACorp assesses
the viability of cutting-edge medical technologies, thus giving decision makers
the information they need to perform. Leerink Swann is a member of FINRA/SIPC.
For more information, visit www.leerink.com.Leerink Swann
Gregg DiPietro, 617-918-4601
Gregg.DiPietro@leerink.com
or
Schwartz Communications
Risa Burgess or Justin Drake
781-684-0770
Leerink@schwartz-pr.comCopyright Business Wire 2009